Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Do young adults know enough about HPV? new survey reveals gaps

NCT ID NCT07418203

Knowledge-focused Sponsor: Université de Reims Champagne-Ardenne Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study surveyed 29 people aged 18-19 in France to find out what they know about human papillomavirus (HPV) and the HPV vaccine. The goal was to identify gaps in knowledge that could be addressed through better education. The results may help improve vaccination rates and informed decision-making.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could highlight where education about HPV and its vaccine is lacking, helping to design better awareness campaigns.
What could go wrong
This is a small, completed survey of only 29 people in France, so the findings may not apply to other groups or countries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

29 people

The number who actually took part.

Started

Dec 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

girls and boys aged 18 to 19 years old

Ages

18 to 19 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Boys and girls 18 to 19 years of age Vaccinated or not against HPV Sexually active or not Agreeing to take part in the study Exclusion Criteria: Minors Age 20 and over Protected by law (guardianship, curatorship, safeguard of justice) Not wishing to answer the questionnaire

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Human papillomavirus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Human papillomavirus

Contacts and locations

Locations

  • Ufr Medecine Urca

    Reims, 51100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.